Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis

Conclusions: PLK1 could be a promising progression marker for OSCC. Therapeutically, targeting PLK1 may be a new approach to fight oral cancer.

Source: Indian Journal of Dental Research - April 10, 2018 Category: Dentistry Authors: Kavitha Vittal Sathasivasubramanian Sankara Pandian Leena Dennis Joseph Shilpa Germaine Raj Source Type: research